162 related articles for article (PubMed ID: 38591163)
1. Deciphering the role of wound healing genes in skin cutaneous melanoma: Insights into expression, methylation, mutations, and therapeutic implications.
Zhang Y; Gao C; Luo J; Khan A; Salem-Bekhit MM; Salem MM; Qi Z; Jiang B
Int Wound J; 2024 Apr; 21(4):e14807. PubMed ID: 38591163
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting IL11RA to mitigate hepatic metastasis in skin cutaneous melanoma: Comprehensive insights from in vitro and in vivo investigations.
Zhang ZG; Zhu HM; Hua HK
Skin Res Technol; 2024 Mar; 30(3):e13618. PubMed ID: 38468436
[TBL] [Abstract][Full Text] [Related]
3. Investigation of GPR143 as a promising novel marker for the progression of skin cutaneous melanoma through bioinformatic analyses and cell experiments.
Bai R; Yin P; Xing Z; Wu S; Zhang W; Ma X; Gan X; Liang Y; Zang Q; Lei H; Wei Y; Zhang C; Dai B; Zheng Y
Apoptosis; 2024 Apr; 29(3-4):372-392. PubMed ID: 37945816
[TBL] [Abstract][Full Text] [Related]
4. LSM2 is associated with a poor prognosis and promotes cell proliferation, migration, and invasion in skin cutaneous melanoma.
Sun X; Zhang J; Hu J; Han Q; Ge Z
BMC Med Genomics; 2023 Jun; 16(1):129. PubMed ID: 37312186
[TBL] [Abstract][Full Text] [Related]
5. Identifying and validating MMP family members (MMP2, MMP9, MMP12, and MMP16) as therapeutic targets and biomarkers in kidney renal clear cell carcinoma (KIRC).
Li K; Li D; Hafez B; Bekhit MMS; Jardan YAB; Alanazi FK; Taha EI; Auda SH; Ramzan F; Jamil M
Oncol Res; 2024; 32(4):737-752. PubMed ID: 38560573
[TBL] [Abstract][Full Text] [Related]
6. The integration of single-cell sequencing, TCGA, and GEO data analysis revealed that PRRT3-AS1 is a biomarker and therapeutic target of SKCM.
Zhang W; Xie X; Huang Z; Zhong X; Liu Y; Cheong KL; Zhou J; Tang S
Front Immunol; 2022; 13():919145. PubMed ID: 36211371
[TBL] [Abstract][Full Text] [Related]
7. α-Enolase inhibits apoptosis and promotes cell invasion and proliferation of skin cutaneous melanoma.
Zhang K; Tian R; Zhang W; Li Y; Zeng N; Liang Y; Tang S
Mol Biol Rep; 2022 Sep; 49(9):8241-8250. PubMed ID: 35925486
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of SNHG16(lncRNA)-Hsa-Let-7b-5p(miRNA)-TUBB4A (mRNA) Pathway Fuels Progression of Skin Cutaneous Melanoma.
Chen G; Yan J
Curr Protein Pept Sci; 2022; 23(11):791-809. PubMed ID: 36173063
[TBL] [Abstract][Full Text] [Related]
9. FANCI serve as a prognostic biomarker correlated with immune infiltrates in skin cutaneous melanoma.
Cai Z; Duan Y; Li W; Liu Z; Gong Z; Hong S; He X; Xuanyuan X; Chen Y; Bi X; Wang W
Front Immunol; 2023; 14():1295831. PubMed ID: 38077326
[TBL] [Abstract][Full Text] [Related]
10. Aspartate beta-hydroxylase domain containing 1 as a prognostic marker associated with immune infiltration in skin cutaneous melanoma.
Sun S; Deng M; Wen J; Chen X; Xu J; Liu Y; Wan H; Wang J; Yan L; He Y; Xu Y
BMC Cancer; 2023 Mar; 23(1):292. PubMed ID: 37004045
[TBL] [Abstract][Full Text] [Related]
11. Integrative lactylation and tumor microenvironment signature as prognostic and therapeutic biomarkers in skin cutaneous melanoma.
Zhu Y; Song B; Yang Z; Peng Y; Cui Z; Chen L; Song B
J Cancer Res Clin Oncol; 2023 Dec; 149(20):17897-17919. PubMed ID: 37955686
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
Tian Q; Gao H; Zhao W; Zhou Y; Yang J
Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
[TBL] [Abstract][Full Text] [Related]
13. ALKBH5 facilitates the progression of skin cutaneous melanoma via mediating ABCA1 demethylation and modulating autophagy in an m
Wang H; Zhao S; Liu H; Liu Y; Zhang Z; Zhou Z; Wang P; Qi S; Xie J
Int J Biol Sci; 2024; 20(5):1729-1743. PubMed ID: 38481816
[No Abstract] [Full Text] [Related]
14. AURKA is a prognostic potential therapeutic target in skin cutaneous melanoma modulating the tumor microenvironment, apoptosis, and hypoxia.
Long S; Zhang XF
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3089-3107. PubMed ID: 35870015
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of the prognosis and biological significance for IFIT family in skin cutaneous melanoma.
Jiang Y; Zhang C; Zhang J; Han D; Shi X
Int Immunopharmacol; 2021 Dec; 101(Pt A):108344. PubMed ID: 34763233
[TBL] [Abstract][Full Text] [Related]
16. System analysis based on the pyroptosis-related genes identifes GSDMD as a novel therapy target for skin cutaneous melanoma.
Zhao S; Zhu Y; Liu H; He X; Xie J
J Transl Med; 2023 Nov; 21(1):801. PubMed ID: 37950289
[TBL] [Abstract][Full Text] [Related]
17. Expression profile and prognostic values of LSM family in skin cutaneous melanoma.
Sun X; Zhang J; Xiao C; Ge Z
BMC Med Genomics; 2022 Nov; 15(1):238. PubMed ID: 36371223
[TBL] [Abstract][Full Text] [Related]
18. Analysis of differential gene immune infiltration and clinical characteristics of skin cutaneous melanoma based on systems biology and drug repositioning methods to identify drug candidates for skin cutaneous melanoma.
Long S; Xu J; Huang H
Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2427-2447. PubMed ID: 37086280
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis reveals SMARCD1 is a potential biomarker and therapeutic target in skin cutaneous melanoma.
Chen J; Yu N; Ou S; Wang X; Li H; Zhu H
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11619-11634. PubMed ID: 37401939
[TBL] [Abstract][Full Text] [Related]
20. Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma.
Fan Y; Liang X; Yu D
Aging (Albany NY); 2021 Oct; 13(19):23036-23071. PubMed ID: 34613934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
